Imagen de Portada
Código QR

Update: detection of a verona integron-encoded metallo-beta-lactamase in Klebsiella pneumoniae -- United States, 2010.

In July 2010, CDC was notified of a patient with a carbapenem-resistant Klebsiella pneumoniae strain that produced a Verona integron-encoded metallo-beta-lactamase (VIM) carbapenemase not reported previously among Enterobacteriaceae in the United States. The patient was a woman from the United State...

Descripción completa

Publicado en:MMWR: Morbidity & Mortality Weekly Report Vol. 59; no. 37; pp. 1212 - 1213
Formato: case study Journal Article
Publicado: Centers for Disease Control & Prevention (CDC) 9/24/2010
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105105699&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105105699
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01492195
        MMW
      jtl: MMWR: Morbidity & Mortality Weekly Report
      issn: 01492195
      maglogo: N
    pubinfo:
      dt: 9/24/2010
      vid: 59
      iid: 37
      pid: 1493
      pub: Centers for Disease Control & Prevention (CDC)
      place: Atlanta, Georgia
    artinfo:
      ui:
        105105699
        105105699
        2010799196
        NLM20864922
        105105699
      ppf: 1212
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Update: detection of a verona integron-encoded metallo-beta-lactamase in Klebsiella pneumoniae -- United States, 2010.
      aug:
      sug:
        subj:
          Hydrolases
          Kidney Failure, Acute Microbiology
          Klebsiella
          Klebsiella Infections Microbiology
          Sepsis Microbiology
          Diarrhea Microbiology
          Drug Resistance, Microbial
          Greece
          Klebsiella Infections Complications
          Klebsiella Infections Drug Therapy
          Male
          Sepsis Drug Therapy
          Travel
          United States
          Male
      ab: In July 2010, CDC was notified of a patient with a carbapenem-resistant Klebsiella pneumoniae strain that produced a Verona integron-encoded metallo-beta-lactamase (VIM) carbapenemase not reported previously among Enterobacteriaceae in the United States. The patient was a woman from the United States who became ill with diarrhea during a Mediterranean cruise and was hospitalized in Greece, where she received a diagnosis of sepsis and Clostridium difficile infection. After 12 days in two hospitals in Greece, she was transferred to a hospital in the United States for continued management of sepsis and acute renal failure. On admission, blood was drawn for culture through a central venous catheter that had been placed while the patient was hospitalized in Greece. The blood subsequently grew carbapenemase-producing Klebsiella pneumoniae exhibiting the VIM resistance mechanism, which has been described previously in Greece but not in the United States. Further testing showed the isolate to be nonsusceptible to all antimicrobials usually used to treat Klebsiella. Despite the resistance of the Klebsiella strain, the patient recovered sufficiently to be discharged after 26 days in the U.S. hospital. A search for other patients colonized with the same isolate was conducted by screening 22 patients whose U.S. hospital stays overlapped with this patient; no carbapenem-resistant Enterobacteriaceae (CRE) were detected.
      pubtype: Academic Journal
      doctype:
        case study
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N